3 June 1992. Accepted 7 July 1992 Schwab et all described the impaired ability of patients with Parkinson's disease to perform two simultaneous tasks, squeezing a bulb ergograph with one hand and drawing triangles with the other. Although the patients were able to perform the drawing task relatively well, the squeezing performance was interrupted by gaps during which the subject would cease to respond for seconds at a time. Schwab and colleagues' coined the term "asynkinesia" to describe this inability to from an unpublished dissertation of Gill8 (cited in 3) in which similar deficits were reported in untreated depressed patients.
The aim of the present study was to assess patients with three neurological diseases, Parkinson's, Huntington's and cerebellar disease, to determine whether qualitatively and quantitatively, different patterns of performance are observed in diseases affecting distinct neuroanatomical regions.
Method Subjects Four groups of subjects participated. The first group consisted of 12 control subjects, none of which had a history of head injury or neurological disease, or were taking any psychoactive medication. Their mean age was 53-4 years (SD 12-7). Three were male and nine female. Ten were right handed and two predominantly left handed. In the second group, there were seven patients with idiopathic Parkinson's disease. Their mean age was 61-0 years (SD 10b4), with a mean duration of illness of 6-7 years (SD 4.2). All patients were maintained on dopaminergic therapy (mean levodopa dose 564 mg/day, SD 201 with a peripheral decarboxylase inhibitor). Before testing, all patients were withdrawn from medication overnight (mean time since last tablet 13-7 hours, SD 5 3). At the time of testing, one patient was in Hoehn and Yahr's9 stage I, two in stage II and four in stage III. Mean Webster rating'0 was 13-7 (SD 5 3) (range 7-22). The group consisted of four men and three women. Five were right handed and two predominantly left handed. Seven patients with late onset cerebellar degeneration comprised the third group. Their mean age was 59 4 years (SD 6 0) with a mean duration of illness of 9 4 years (SD . None of the patients were taking any medication at the time of testing. Three were men and four women. All were right handed. In the fourth group, there were six patients with Huntington's disease with a mean age of 44-0 years (SD 14-2) and a mean duration of illness of 4-7 years (SD 2-8). Mean disease severity score on the Marsden and Quinn scale" was 10-5 (SD 8-3) (range 2-23). Five of the patients were taking no psychoactive medication, and one was taking haloperidol (500 gg/day, last dose 12 hours previously). The order of testing was randomised across subjects. All subjects were assessed on the Mini-Mental State Examination (MMS).'3
Results
The difference between the mean ages of the four groups approached significance (F(3,28) = 2-9, p = 0 05), although paired comparisons using the Scheffe test revealed that no two groups differed significantly. The mean (and SD) of the MMS scores were: controls 28-8 (1A4); patients with Parkinson's 29'0 (1 0); Huntingdon's 27-1 (2-3); and cerebellar degeneration 29 0 (1 1). The difference in group means approached, but did not reach significance (F(3,28) = 2-5, p = 0'08). Despite the marginal significance of the group differences in age and MMS scores, the data were analysed both with and without age and MMS score as covariates. There were no differences between the patterns of results in the two sets of analyses, and so only those performed without a covariate will be reported.
The table shows the mean performance of the four groups for each of the test conditions, as well as the performance in the bimanual conditions expressed as a percentage of unimanual task performance. Also shown are the results of the oneway analyses of variance and, where significant, the results of the paired comparisons using the Scheffe test. For the pegboard, the three patient groups were significantly slower than the controls for both unimanual and bimanual performance. The number placed in the bimanual condition as a percentage of the unimanual condition was very similar in the four groups. An identical pattern was found for unimanual and bimanual tapping. In the bimanual combinations of tapping and pegboard, as expected, the absolute number of pegs/taps was less in the patient groups. M9re meaningful, however, are the percentage results. Pegboard performance while tapping was very close to the unimanual pegboard performance. With the tapping data, the groups with Parkinson's and cerebellar degeneration performed worse than the controls. The performance of the patients with Huntingdon's disease was midway between that of the controls and those with Parkinsonism, and did not differ significantly from either.
Discussion
The pattern of performance in the patients with Parkinson's disease was consistent with previous reports. Although slower overall, they were not impaired in the speed/accuracy of bimanual movements relative to their unimanual performance when the bimanual task involved the same action with both hands. This was true whether the task was finger tapping or pegboard performance. When pegboard performance was combined with finger tapping, pegboard performance was not affected. If anything, it was slightly improved over the unimanual condition. In contrast, tapping performance was dramatically reduced to only 55% of the unimanual score. The patients appeared to be able to maintain performance on the task requiring visual control of placing pegs, while the repetitive, nonvisually guided task (tapping) suffered. While these results replicate earlier reports, an important new finding is that exactly the same pattern of results was shown by the group of patients with cerebellar disease. The performance of the group with Huntingdon's disease was similar, with the exception that they were less impaired on the combined bimanual task. In particular, they were able to tap better than other two patient groups while placing pegs. These results suggest that a deficit in performing bimanual movements is found in patients with Parkinson's and cerebellar disease, and to a lesser extent, in those with Huntingdon's. This deficit therefore cannot be considered a specific indicator of motor dysfunction in patients with Parkinsonism. This finding has a number of interpretations. First, the deficit may be non-specific and be sensitive to any type of brain damage. Second, the deficits in the groups with Parkinsonism and cerebellar degeneration might indicate disruption to a common functional system which is affected less by the pathology of Huntingdon's. Third, the behavioural deficits in the three groups might result from quite different mechanisms. Further research should focus on the precise mechanisms underlying the difficulties experienced by patients with motor disorders in performing bimanual movements. 
